Pharmacogenomics of anti-platelet therapy focused on peripheral blood cells of coronary arterial disease patients.


BACKGROUND To investigate genes differentially expressed in peripheral blood cells (PBCs) from patients with coronary arterial disease (CAD) under double anti-platelet therapy. METHODS Twenty-six CAD patients that were submitted to percutaneous coronary intervention (PCI) were selected to participate in this study. These patients took 100mg/day of… (More)
DOI: 10.1016/j.cca.2013.06.021


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics